| abstract |
PROBLEM TO BE SOLVED: To provide a novel polynucleotide which is used for treating diseases of meningitis such as otitis media, especially infection of cerebrospinal fluid, and in particular, elicits an immune response against Streptococcus nimononiae bacteria. Provision of a polypeptide expressed therefrom. SOLUTION: A polynucleotide having a specific base sequence and a polypeptide having a specific amino acid sequence, and fragments and variants thereof. A vector comprising the polynucleotide. A method for producing the polypeptide by culturing a host containing the vector. An antibody against the polypeptide. The present invention relates to a treatment method and the like by administration of the polypeptide. |